Categories News Press Releases Archives 2025 July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August June May March February January 2021 December November October September August May April February Jun 27 UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder Read More Share:| | | Jun 20 UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference Read More Share:| | | Jun 17 Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S. Read More Share:| | | Jun 13 Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis Read More Share:| | | Jun 12 UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity Read More Share:| | | Jun 11 BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis Read More Share:| | | Jun 04 Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs Read More Share:| | | Jun 02 Partnering with Patient Communities to Advance HS Awareness and Care Read More Share:| | |